Navigation Links
Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy

Monday saw the conclusion of the first of a wave of prescription drug trials with the hearing of the closing arguments as Wyeth defended// its hormone replacement therapy Prempro against claims of increased risk of heart disease, stroke and cancer.

Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the jury at the federal court in Little Rock said, "Wyeth was negligent in not testing the drug and not knowing the truth about their drug."

However Wyeth's lawyer Jane Bockus told the panel of nine women and three men that the company had been warning doctors as early as 1991 of a reported increase in malignancies among patients taking its hormone replacement therapy and that the therapy should not be prescribed for over a year without a follow-up exam.

On Reeves testimony it was revealed that she took Prempro for more than eight years.

Bockus said, "Clearly the label contained adequate information," to allow doctors to decide on patient treatment.

This is the first trial of 5,000 lawsuits filed against Wyeth for Prempro.

Reeves, 67, and her lawyer told the jury at the U.S. Court for the Eastern District of Arkansas that consuming Prempro caused the growth of a breast tumor, for which she had to undergo a mastectomy.

Prempro is a combination of the hormones estrogen and progesterone to overcome the effects of menopause and has been sold in the United States since 1995.

Wyeth’s lawyers argued that the drug company had met its ethical and legal obligations in determining the treatment's safety, before U.S. District Judge William R. Wilson, Jr.

Reeves’ lawyers have said that she is seeking an unspecified judgment that could exceed $1 million.


NL
'"/>




Page: 1

Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Pharma Wins Law Suit
3. Verdict Against Wyeth Pharma in Prempro Case
4. Simmering Curry - Murg Masala Embroiled In a Thick Soup
5. Medical Education in Australia Embroiled in Scandals
6. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
7. Lawsuit Against Sunscreen Makers For False Claims of Protection Against Skin Cancer
8. Lawsuit against Google
9. KFC Targeted in Lawsuit
10. American Wins Lawsuit Over Penile Implant Malfunction
11. Soft Drink Companies Settle Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... In just two ... Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone so ... nearly 2,000 consumers (and counting) already backing the campaign. , “We are ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will ... The majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... ) announced their partnership to prep patients for colonoscopy at the HyGIeaCare® Center ... in 87th Ave., Miami, FL. , The HyGIeaCare® Prep, cleared by ...
(Date:3/24/2017)... ... 24, 2017 , ... “Finding Christ Through Social Media: Year ... chronicling the writer’s path toward true communion with God. “Finding Christ Through Social ... the creation of published author Lea Michelle Johnson, a follower of Christ, wife ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The ... about real people of God in congregations across the United States. “The ... minister ordained in 1964 who has served congregations in seven states throughout his ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Ascendis Pharma ... innovative TransCon technology to address significant unmet medical needs ... host a conference call and webcast on Monday, April ... Endocrine Society in Orlando, Florida , ... pipeline candidates (TransCon Growth Hormone, TransCon PTH and TransCon ...
(Date:3/23/2017)... DIEGO , March 23, 2017  A ... fast and accurate identification of individuals who carry ... risk for a rare yet potentially deadly side ... and bipolar disorder.  The gene HLA-B*15:02 ... reactions such as Stevens-Johnson syndrome and toxic epidermal ...
(Date:3/23/2017)... Prima BioMed has presented encouraging ... IMP321 in combination with Keytruda, with one of the ... a complete response. Recruitment in the second cohort is ... fully recruited by Q317. Preliminary efficacy data from the ... are expected mid-year (recruitment in the 226-patient Phase IIb ...
Breaking Medicine Technology: